Bacillus subtilis GlcK activity requires cysteines within a motif that discriminates microbial glucokinases into two lineages.

BMC Microbiol

Department of Microbiology, Institute for Microbiology, Biochemistry and Genetics, University of Erlangen-Nuremberg, Staudstrasse 5, 91058 Erlangen, Germany.

Published: February 2004

Background: Bacillus subtilis glucokinase (GlcK) (GenBank NP_390365) is an ATP-dependent kinase that phosphorylates glucose to glucose 6-phosphate. The GlcK protein has very low sequence identity (13.7%) to the Escherichia coli glucokinase (Glk) (GenBank P46880) and some other glucokinases (EC 2.7.1.2), yet glucose is merely its substrate. Our lab has previously isolated and characterized the glcK gene.

Results: Microbial glucokinases can be grouped into two different lineages. One of the lineages contains three conserved cysteine (C) residues in a CXCGX(2)GCXE motif. This motif is also present in the B. subtilis GlcK. The GlcK protein occurs in both monomer and homodimer. Each GlcK monomer has six cysteines. All cysteine residues have been mutated, one-by-one, into alanine (A). The in vivo GlcK enzymatic activity was assayed by functional complementation in E. coli UE26 (ptsG ptsM glk). Mutation of the three motif-specific residues led to an inactive enzyme. The other mutated forms retained, or in one case (GlcKC321A) even gained, activity. The fluorescence spectra of the GlcKC321A showed a red shift and enhanced fluorescence intensity compare to the wild type's.

Conclusions: Our results emphasize the necessity of cysteines within the CXCGX(2)GCXE motif for GlcK activity. On the other hand, the C321A mutation led to higher GlcKC321A enzymatic activity with respect to the wild type's, suggesting more adequate glucose phosphorylation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC365027PMC
http://dx.doi.org/10.1186/1471-2180-4-6DOI Listing

Publication Analysis

Top Keywords

glck
9
bacillus subtilis
8
subtilis glck
8
glck activity
8
microbial glucokinases
8
glck protein
8
cysteine residues
8
cxcgx2gcxe motif
8
enzymatic activity
8
activity
5

Similar Publications

Article Synopsis
  • Pathogenic free-living amoebae (pFLA) pose serious risks for central nervous system infections, making it crucial to find new chemical agents to fight these pathogens.
  • The study focuses on glucokinase (Glck), a metabolic enzyme with minimal similarity to human counterparts, as a promising target for developing inhibitors.
  • Using a novel "shotgun" multifragment kinetic target-guided synthesis (KTGS) strategy, researchers identified 12 effective inhibitors against three different pFLA glucokinase enzymes, showcasing KTGS's effectiveness even in the absence of detailed structural information.
View Article and Find Full Text PDF

Microbial production of aromatic compounds is an attractive and sustainable biotechnological approach. With this motivation, here metabolic engineering of Corynebacterium glutamicum for l-tyrosine (l-Tyr) overproduction was attempted by pushing the carbon flux more towards l-Tyr. Translational start codon exchanges of prephenate dehydratase (pheA), anthranilate synthase (trpE), and phenylalanine aminotransferase (pat) genes revealed that reduced expression of pheA was the major contributor to increased l-Tyr titer while codon exchange in trpE was effective to a lower extent.

View Article and Find Full Text PDF

Characterization of Glucokinases from Pathogenic Free-Living Amoebae.

Antimicrob Agents Chemother

June 2022

Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson Universitygrid.26090.3d, Clemson, South Carolina, USA.

Infection with pathogenic free-living amoebae, including Naegleria fowleri, spp., and Balamuthia mandrillaris, can lead to life-threatening illnesses, primarily because of catastrophic central nervous system involvement. Efficacious treatment options for these infections are lacking, and the mortality rate due to infection is high.

View Article and Find Full Text PDF

A rare stereoisomer of inositol, scyllo-inositol, is a therapeutic agent that has shown potential efficacy in preventing Alzheimer's disease. Mycobacterium tuberculosis ino1 encoding myo-inositol-1-phosphate (MI1P) synthase (MI1PS) was introduced into Bacillus subtilis to convert glucose-6-phosphate (G6P) into MI1P. We found that inactivation of pbuE elevated intracellular concentrations of NAD·NADH as an essential cofactor of MI1PS and was required to activate MI1PS.

View Article and Find Full Text PDF

Enzymatic and Structural Characterization of the Glucokinase.

Antimicrob Agents Chemother

May 2019

Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, USA

Infection with the free-living amoeba leads to life-threatening primary amoebic meningoencephalitis. Efficacious treatment options for these infections are limited, and the mortality rate is very high (∼98%). Parasite metabolism may provide suitable targets for therapeutic design.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!